Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A cerebrospinal fluid microRNA analysis: Progressive supranuclear palsy

14 Jan 2022

Abstract excerpt

Progressive supranuclear palsy (PSP) is a neurodegenerative tauopathy described as a syndrome of postural instability, supranuclear vertical gaze palsy, dysarthria, dystonic rigidity of the neck and trunk, dementia, and pseudobulbar palsy. The clinical diagnosis of PSP is often difficult because there are no established biomarkers, and diagnosis is currently based on clinical and imaging findings. Furthermore,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neurological diseases and metabolism
Share to Parkinson's Disease Mechanisms and Treatments
Share to RNA regulation and disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35039873
DOI: 10.3892/mmr.2022.12604

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A cerebrospinal fluid microRNA analysis: Progressive supranuclear palsyPMID 35039873Read ↗

The diagnosis of progressive supranuclear palsy: current opinions and challenges.Semantic proximity Read ↗

Biomarker discovery in progressive supranuclear palsy from human cerebrospinal fluid using mass spectrometry-based proteomicsSemantic proximity Read ↗

CSF Proteomics in Patients With Progressive Supranuclear PalsySemantic proximity Read ↗

Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges.Semantic proximity Read ↗

Progressive supranuclear palsy: current approach and challenges to diagnosis and treatment.Semantic proximity Read ↗

Plasma miRNA Biomarker Signatures in Parkinsonian SyndromesSemantic proximity Read ↗

Genetics of Progressive Supranuclear Palsy: A ReviewSemantic proximity Read ↗

Progressive Supranuclear Palsy: an Update.Semantic proximity Read ↗

miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson’s diseaseSemantic proximity Read ↗

Novel Therapeutic Targets and Biomarkers for the Treatment of Progressive Supranuclear PalsySemantic proximity Read ↗

The phenotypic spectrum of progressive supranuclear palsy.Semantic proximity Read ↗

MicroRNA biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive reviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.